Literature DB >> 24272883

Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals.

Aamir Ahmad1, Yiwei Li, Bin Bao, Dejuan Kong, Fazlul H Sarkar.   

Abstract

Nutraceuticals, the bioactive food components represented by many naturally occurring dietary compounds, have been investigated for a few decades for their numerous beneficial effects, including their anticancer properties. The initial interest in the cancer-preventing/therapeutic ability of these agents was based on their ability to affect multiple signaling pathways that are deregulated in cancer cells. With a shift in the focus of cancer research to the emerging areas such as epigenetic regulation, microRNAs (miRNAs) and the cancer stem cells (CSCs), nutraceuticals initially appeared out of place. However, research investigations over the last several years have slowly but firmly presented evidence that supports a relevance of these agents in modern day research. While nutraceuticals are increasingly being realized to alter miRNA/CSCs expression and function, the molecular mechanism(s) are not very clearly understood. Epigenetic regulation is one mechanism by which these agents exert their anticancer effects. In this focused mini review, we summarize our current understanding of epigenetic regulation of miRNAs and CSCs by nutraceuticals. We discuss both direct and indirect evidences that support such an activity of these compounds.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Cancer stem cells; Epigenetic regulation; Nutraceuticals; miRNA

Mesh:

Substances:

Year:  2013        PMID: 24272883      PMCID: PMC3997058          DOI: 10.1002/mnfr.201300528

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  100 in total

1.  DNA breakage by resveratrol and Cu(II): reaction mechanism and bacteriophage inactivation.

Authors:  A Ahmad; S Farhan Asad; S Singh; S M Hadi
Journal:  Cancer Lett       Date:  2000-06-01       Impact factor: 8.679

Review 2.  MicroRNA, nutrition, and cancer prevention.

Authors:  Sharon A Ross; Cindy D Davis
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

Review 3.  Role of epigenetics in cancer initiation and progression.

Authors:  Flora Chik; Moshe Szyf; Shafaat A Rabbani
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

4.  Sulforaphane causes a major epigenetic repression of myostatin in porcine satellite cells.

Authors:  Huitao Fan; Rui Zhang; Dawit Tesfaye; Ernst Tholen; Christian Looft; Michael Hölker; Karl Schellander; Mehmet Ulas Cinar
Journal:  Epigenetics       Date:  2012-10-23       Impact factor: 4.528

Review 5.  Targeting deregulated epigenetic control in cancer.

Authors:  Sayyed K Zaidi; Andre J Van Wijnen; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2013-11       Impact factor: 6.384

6.  Targeting epigenetics for cancer prevention by dietary cancer preventive compounds--the case of miRNA.

Authors:  Ah-Ng Tony Kong; Chengyue Zhang; Zheng-Yuan Su
Journal:  Cancer Prev Res (Phila)       Date:  2013-06-17

7.  Polycomb group proteins in cell cycle progression and cancer.

Authors:  Diego Pasini; Adrian P Bracken; Kristian Helin
Journal:  Cell Cycle       Date:  2004-04-01       Impact factor: 4.534

Review 8.  DNA methylation profiling in the clinic: applications and challenges.

Authors:  Holger Heyn; Manel Esteller
Journal:  Nat Rev Genet       Date:  2012-09-04       Impact factor: 53.242

9.  Cancer epigenetics: new therapies and new challenges.

Authors:  Eleftheria Hatzimichael; Tim Crook
Journal:  J Drug Deliv       Date:  2013-02-26

Review 10.  Proteomics in epigenetics: new perspectives for cancer research.

Authors:  Till Bartke; Julie Borgel; Peter A DiMaggio
Journal:  Brief Funct Genomics       Date:  2013-02-11       Impact factor: 4.241

View more
  14 in total

1.  Hydroxytyrosol Induces Apoptosis and Cell Cycle Arrest and Suppresses Multiple Oncogenic Signaling Pathways in Prostate Cancer Cells.

Authors:  Haseeb Zubair; Arun Bhardwaj; Aamir Ahmad; Sanjeev Kumar Srivastava; Mohammad Aslam Khan; Girijesh Kumar Patel; Seema Singh; Ajay Partap Singh
Journal:  Nutr Cancer       Date:  2017-07-18       Impact factor: 2.900

2.  Epigenetic inactivation of miR-203 as a key step in neural crest epithelial-to-mesenchymal transition.

Authors:  Estefanía Sánchez-Vásquez; Marianne E Bronner; Pablo H Strobl-Mazzulla
Journal:  Development       Date:  2019-04-11       Impact factor: 6.868

Review 3.  Epigenetic basis of cancer health disparities: Looking beyond genetic differences.

Authors:  Aamir Ahmad; Shafquat Azim; Haseeb Zubair; Mohammad Aslam Khan; Seema Singh; James E Carter; Rodney P Rocconi; Ajay P Singh
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-01-17       Impact factor: 10.680

4.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

5.  Epigenetic basis of cancer drug resistance.

Authors:  Moammir H Aziz; Aamir Ahmad
Journal:  Cancer Drug Resist       Date:  2020-03-19

Review 6.  Molecular targets of naturopathy in cancer research: bridge to modern medicine.

Authors:  Aamir Ahmad; Kevin R Ginnebaugh; Yiwei Li; Subhash B Padhye; Fazlul H Sarkar
Journal:  Nutrients       Date:  2015-01-06       Impact factor: 5.717

7.  miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation.

Authors:  Tongbao Feng; Fang Shao; Qiyong Wu; Xiaohang Zhang; Dongqin Xu; Keqing Qian; Yewen Xie; Shizhong Wang; Ning Xu; Yong Wang; Chunjian Qi
Journal:  Oncotarget       Date:  2016-03-29

Review 8.  MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers.

Authors:  Ammad Ahmad Farooqi; Sobia Tabassum; Aamir Ahmad
Journal:  Int J Mol Sci       Date:  2017-10-02       Impact factor: 5.923

9.  Synergistic transcriptional and post-transcriptional regulation of ESC characteristics by core pluripotency transcription factors in protein-protein interaction networks.

Authors:  Leijie Li; Liangcai Zhang; Guiyou Liu; Rennan Feng; Yongshuai Jiang; Lei Yang; Shihua Zhang; Mingzhi Liao; Jinlian Hua
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

10.  MiR-367 negatively regulates apoptosis induced by adriamycin in osteosarcoma cells by targeting KLF4.

Authors:  Guang-Chao Wang; Qian-Yun He; Da-Ke Tong; Chuan-Feng Wang; Kang Liu; Chen Ding; Fang Ji; Hao Zhang
Journal:  J Bone Oncol       Date:  2016-02-17       Impact factor: 4.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.